期刊
AMERICAN JOURNAL OF ROENTGENOLOGY
卷 211, 期 2, 页码 267-277出版社
AMER ROENTGEN RAY SOC
DOI: 10.2214/AJR.18.19881
关键词
Ga-68-DOTATATE; neuroendocrine tumor; PET/CT
OBJECTIVE. The purpose of this article is to provide a review of the use of Ga-68-tetraazacyclododecanetetraacetic acid-DPhe1-Tyr3-octreotate (DOTATATE) PET/CT, a functional imaging modality for assessment of well-differentiated neuroendocrine tumors (NETs). It has become the preferred imaging modality for initial diagnosis, selection of patients for peptide receptor radionuclide therapy, and localization of unknown primary tumors. The National Comprehensive Cancer Network guideline has added Ga-68-DOTATATE PET/CT as an appropriate test in the management of NETs. CONCLUSION. In combination with FDG PET/CT, Ga-68-DOTATATE PET/CT can noninvasively assess tumor heterogeneity, especially in G2 and G3 NETs, for personalized management of patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据